A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis; BREEZE-AD3

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleA Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis; BREEZE-AD3
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsYoung-Wook Lee